Financhill
Back

Microsoft Corp. Vs. Cidara Therapeutics, Inc. Sector Stock Comparison

Sell
41

MSFT
Microsoft Corp.

Last Price:
$478.37
Seasonality Move:
5.2%
Buy
77

CDTX
Cidara Therapeutics, Inc.

Last Price:
$220.65
Seasonality Move:
9.28%
Sell
41
Microsoft Corp. (MSFT) is a Sell

Is Microsoft Corp. a Buy, Sell or Hold?

  • The current Microsoft Corp. [MSFT] share price is $483.47. The Score for MSFT is 41, which is 18% below its historic median score of 50, and infers higher risk than normal.
  • MSFT is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
77
Cidara Therapeutics, Inc. (CDTX) is a Buy

Is Cidara Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Cidara Therapeutics, Inc. [CDTX] share price is $220.65. The Score for CDTX is 77, which is 54% above its historic median score of 50, and infers lower risk than normal.
  • CDTX is currently trading in the 70-80% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

MSFT Stock Price Chart

What is Microsoft Corp.'s stock price today?

  • The Microsoft Corp. share price today is $483.47
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and MSFT is experiencing slight buying pressure.

CDTX Stock Price Chart

What is Cidara Therapeutics, Inc.'s stock price today?

  • The Cidara Therapeutics, Inc. share price today is $220.65
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CDTX is experiencing buying pressure, which is a positive indicator for future bullish movement.

MSFT Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -6.05 Sell
Relative Strength Index (14 RSI): 44.19 Sell
Chaikin Money Flow: 12249691 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (478.86 - 502.28) Sell
Bollinger Bands (100): (494.33 - 523.73) Sell

CDTX Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 21.57 Buy
Relative Strength Index (14 RSI): 86.06 Buy
Chaikin Money Flow: 367727 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (151.4 - 242.46) Buy
Bollinger Bands (100): (51.44 - 167.06) Buy

MSFT Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 484.6 Sell
20-day SMA: 487.22 Sell
50-day SMA: 505.41 Sell
200-day SMA: 471.47 Buy
8-day EMA: 484.75 Sell
20-day EMA: 489.24 Sell
50-day EMA: 498.47 Sell
200-day EMA: 480.77 Buy

CDTX Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 220.33 Buy
20-day SMA: 219.69 Buy
50-day SMA: 150.04 Buy
200-day SMA: 68.84 Buy
8-day EMA: 219.45 Buy
20-day EMA: 204.15 Buy
50-day EMA: 162.92 Buy
200-day EMA: 88.08 Buy

Microsoft Corp. Earnings Growth & MSFT Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.63 per share, a decrease next quarter of $0.00 per share, an increase this year of $1.59 per share, and an increase next year of $2.81 per share.

Cidara Therapeutics, Inc. Earnings Growth & CDTX Earnings Dates

  • Analysts estimate an earnings increase this quarter of $1.42 per share, a decrease next quarter of $0.00 per share, an increase this year of $14.86 per share, and an increase next year of $1.78 per share.

Microsoft Corp. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Cidara Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):